Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
Y
Yizhen Fu
(Sun Yat-sen University Cancer Center, Guangzhou, China)
Y
Yaojun Zhang
D
Dandan Hu
Z
Zhongguo Zhou
L
Li Xu
M
Minshan Chen
(Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 43, Issue 14
Published
May 10, 2025
Pages
1625-1630
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (6)
Y
Yizhen Fu
Sun Yat-sen University Cancer Center, Guangzhou, China
Y
Yaojun Zhang
D
Dandan Hu
Z
Zhongguo Zhou
L
Li Xu
M
Minshan Chen
Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001